Half-year report · Q2

Period2024-06-01 → 2024-11-30
Filed2025-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥31.4bn2024-06-01 → 2024-11-30Cons.Net sales
Revenue¥61.6bn2023-06-01 → 2024-05-31Cons.Net sales (5-year summary)
Revenue¥28.9bn2023-06-01 → 2023-11-30Cons.Net sales
Operating income¥522m2024-06-01 → 2024-11-30Cons.Operating income
Operating income¥618m2023-06-01 → 2023-11-30Cons.Operating income
Ordinary income¥552m2024-06-01 → 2024-11-30Cons.Ordinary income
Ordinary income¥1.0bn2023-06-01 → 2024-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥645m2023-06-01 → 2023-11-30Cons.Ordinary income
Profit before tax¥586m2024-06-01 → 2024-11-30Cons.Income before income taxes
Profit before tax¥700m2023-06-01 → 2023-11-30Cons.Income before income taxes
Net income (owners)¥338m2024-06-01 → 2024-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥580m2023-06-01 → 2024-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥480m2023-06-01 → 2023-11-30Cons.Profit loss attributable to owners of parent
Net income¥337m2024-06-01 → 2024-11-30Cons.Profit loss
Net income¥477m2023-06-01 → 2023-11-30Cons.Profit loss
Total assets¥26.4bnat 2024-11-30Cons.Assets
Total assets¥26.6bnat 2024-05-31Cons.Assets
Total assets¥24.8bnat 2023-11-30Cons.Total assets (5-year summary)
Total liabilities¥17.7bnat 2024-11-30Cons.Liabilities
Total liabilities¥18.0bnat 2024-05-31Cons.Liabilities
Net assets / equity¥8.7bnat 2024-11-30Cons.Net assets
Net assets / equity¥8.6bnat 2024-05-31Cons.Net assets
Net assets / equity¥8.3bnat 2023-11-30Cons.Net assets (5-year summary)
Cash and deposits¥4.4bnat 2024-11-30Cons.Cash and deposits
Cash and deposits¥5.3bnat 2024-05-31Cons.Cash and deposits
Cash & equivalents¥4.4bnat 2024-11-30Cons.Cash and cash equivalents
Cash & equivalents¥5.3bnat 2024-05-31Cons.Cash and cash equivalents
Cash & equivalents¥5.0bnat 2023-11-30Cons.Cash and cash equivalents
Cash & equivalents¥5.8bnat 2023-05-31dCons.Cash and cash equivalents
Operating cash flow−¥633m2024-06-01 → 2024-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥878m2023-06-01 → 2024-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥544m2023-06-01 → 2023-11-30Cons.Net cash provided by used in operating activities
Investing cash flow¥19m2024-06-01 → 2024-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.1bn2023-06-01 → 2024-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥154m2023-06-01 → 2023-11-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥239m2024-06-01 → 2024-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥335m2023-06-01 → 2024-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥123m2023-06-01 → 2023-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥136.82024-06-01 → 2024-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥227.962023-06-01 → 2024-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥188.052023-06-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio32.9%at 2024-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio32.2%at 2024-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.5%at 2023-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-06-01 → 2024-11-30¥0
Reconciling Itemsreconcilingrevenue intersegment2024-06-01 → 2024-11-30¥0
Reconciling Itemsreconcilingsegment profit2024-06-01 → 2024-11-30−¥519m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2024-06-01 → 2024-11-30¥113m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2024-06-01 → 2024-11-30¥112m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2024-06-01 → 2024-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2024-06-01 → 2024-11-30−¥82m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue2024-06-01 → 2024-11-30¥31.2bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue external2024-06-01 → 2024-11-30¥31.2bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2024-06-01 → 2024-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentsegment profit2024-06-01 → 2024-11-30¥1.1bn
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue2024-06-01 → 2024-11-30¥35m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue external2024-06-01 → 2024-11-30¥35m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentsegment profit2024-06-01 → 2024-11-30¥0
—segment totalrevenue2024-06-01 → 2024-11-30¥31.4bn
—segment totalrevenue external2024-06-01 → 2024-11-30¥31.4bn
—segment totalrevenue intersegment2024-06-01 → 2024-11-30¥0
—segment totalsegment profit2024-06-01 → 2024-11-30¥1.0bn
Reconciling Itemsreconcilingrevenue2023-06-01 → 2023-11-30¥0
Reconciling Itemsreconcilingrevenue intersegment2023-06-01 → 2023-11-30¥0
Reconciling Itemsreconcilingsegment profit2023-06-01 → 2023-11-30−¥494m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2023-06-01 → 2023-11-30¥146m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2023-06-01 → 2023-11-30¥146m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2023-06-01 → 2023-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2023-06-01 → 2023-11-30¥6m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue2023-06-01 → 2023-11-30¥28.7bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue external2023-06-01 → 2023-11-30¥28.7bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2023-06-01 → 2023-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentsegment profit2023-06-01 → 2023-11-30¥1.1bn
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue2023-06-01 → 2023-11-30¥36m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue external2023-06-01 → 2023-11-30¥36m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentsegment profit2023-06-01 → 2023-11-30¥2m
—segment totalrevenue2023-06-01 → 2023-11-30¥28.9bn
—segment totalrevenue external2023-06-01 → 2023-11-30¥28.9bn
—segment totalrevenue intersegment2023-06-01 → 2023-11-30¥0
—segment totalsegment profit2023-06-01 → 2023-11-30¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 485
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember335966
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1362
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember272952
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.1107
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember133132
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0540
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember130000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0527
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember93900
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0381
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember70000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0284
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember62000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0251
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember56600
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0230
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember47533
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0193
Number of shares heldCurrentQuarterInstant1550483
Shareholding ratioCurrentQuarterInstant0.6287
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember86900
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember2462500
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember24625
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember3600
Number of shares issued shares voting rightsCurrentQuarterInstant2553000
Number of voting rights issued shares voting rightsCurrentQuarterInstant24625
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member86900
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member86900
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0340
Number of shares held in own name treasury shares etcCurrentQuarterInstant86900
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant86900
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0340
Cash and depositsPrior1YearInstant5300000000JPY
Cash and depositsCurrentQuarterInstant4447000000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant11610000000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant12029000000JPY
MerchandisePrior1YearInstant2974000000JPY
MerchandiseCurrentQuarterInstant3662000000JPY
Other caPrior1YearInstant1019000000JPY
Other caCurrentQuarterInstant712000000JPY
Allowance for doubtful accounts caPrior1YearInstant-17000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-17000000JPY
Current assetsPrior1YearInstant20887000000JPY
Current assetsCurrentQuarterInstant20835000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-05-31pass rounding
balance sheet identityconsolidated 2024-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-05-31pass
statement vs summary · net assetsconsolidated 2024-11-30pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2023-11-30pass
statement vs summary · net income attributable to parentconsolidated 2024-06-01/2024-11-30pass
statement vs summary · operating cash flowconsolidated 2023-06-01/2023-11-30pass
statement vs summary · operating cash flowconsolidated 2024-06-01/2024-11-30pass
statement vs summary · revenueconsolidated 2023-06-01/2023-11-30pass
statement vs summary · revenueconsolidated 2024-06-01/2024-11-30pass
statement vs summary · total assetsconsolidated 2024-05-31pass
statement vs summary · total assetsconsolidated 2024-11-30pass